Clinical analysis of liver injury caused by Chinese patent medicines containing Polygonum multiflorum

doi:10.5246/jcps.2022.04.026

Abstract

Abstract:

In the present study, we discussed the drug-induced liver injury caused by Chinese patent medicines containing Polygonum multiflorum to provide a reference for clinical rational drug use of Polygonum multiflorum and its preparations. One case of long-term taking Jingwu capsule and Huolisu oral liquid, which led to the drug-induced liver injury, was reported. The other case took Runzaozhiyang capsule for a long time, which also led to drug-induced liver injury. Jingwu capsule, Huolisu oral liquid, and Runzaozhiyang capsule all contained Polygonum multiflorum, which could result in liver injury when used long-term. Moreover, we explored the clinical features and toxicity of liver damage induced by Polygonum multiflorum. Liver damage in serum transaminase was significantly increased, and the increasing rate of ALT was more than that of AST. Jaundice appeared obviously. The liver damage mechanisms included drug metabolism, immune response, physical fitness, and many other reasons. Corresponding suggestions on rational use of Polygonum multiflorum and its preparations were presented. The dosage and period should be regulated. The index of liver function should be monitored during the medication periods. Collectively, patients with a history of liver disease or a history of allergies should pay more attention when using the above-mentioned drugs.

Key words: Drug-induced liver injury, Polygonum multiflorum, Jingwu capsule, Huolisu oral liquid, Runzaozhiyang capsule

Supporting:

Jie Shen, Kai Yang, Caihua Sun, Cheng Jiang, Minxia Zheng. Clinical analysis of liver injury caused by Chinese patent medicines containing Polygonum multiflorum[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(4): 289-297.

Figures/Tables 5

Table 1. The drug combination of the patient who took Jingwu capsule and Huolisu oral liquid (Case 1).

Table 2. Liver and kidney function biochemical immune test of patient who took Jingwu capsule and Huolisu oral liquid (Case 1).

Table 3. The drug combination of the patient who took Runzaozhiyang capsules (Case 2).

Table 4. Liver and kidney function biochemical immune test of patient who took Runzaozhiyang capsule after forty days (Case 2).

Table 5. Liver and kidney function biochemical immune test of patient who took Runzaozhiyang capsule after seventy days (Case 2).

References 20

[1]	Ou, P.C.; Chen, Y.; Li, B.Z.; Zhang, M.; Liu, X.Y.; Li, F.F.; Li, Y.; Chen, C.W.; Mao, Y.M.; Chen, J. Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital. SpringerPlus. 2015, 4, 802.
[2]	Shen, T.; Liu, Y.; Shang, J.; Xie, Q.; Li, J.; Yan, M.; Xu, J.; Niu, J.; Liu, J.; Watkins, P.B.; Aithal, G.P.; Andrade, R.J.; Dou, X.; Yao, L.; Lv, F.; Wang, Q.; Li, Y.; Zhou, X.; Zhang, Y.; Zong, P.; Wan, B.; Zou, Z.; Yang, D.; Nie, Y.; Li, D.; Wang, Y.; Han, X.; Zhuang, H.; Mao, Y.; Chen, C. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 2019, 156, 2230–2241.e11.
[3]	Lin, L.F.; Ni, B.R.; Lin, H.M.; Zhang, M.; Li, X.C.; Yin, X.B.; Qu, C.H.; Ni, J. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J. Ethnopharmacol. 2015, 159, 158–183.
[4]	Li, C.Y.; Li, X.F.; Tu, C.; Li, N.; Ma, Z.J.; Pang, J.Y.; Jia, G.L.; Cui, H.R.; You, Y.; Song, H.B.; Du, X.X.; Zhao, Y.L.; Wang, J.B.; Xiao, X.H. The idiosyncratic hepatotoxicity of Polygonum multiflorum based on endotoxin model. Acta Pharm. Sin. 2015, 50, 28–33.
[5]	Xiao, X. Guidelines for safe use of Polygoni Multiflori Radix. China J. Chin. Mater. Med. 2020, 45, 961–966.
[6]	Jing, J.; Wang, R.L.; Zhao, X.Y.; Zhu, Y.; Niu, M.; Wang, L.F.; Song, X.A.; He, T.T.; Sun, Y.Q.; Xu, W.T.; Yu, S.M.; Wang, L.P.; Guo, Y.M.; Bai, Z.F.; Xiao, X.H.; Wang, J.B. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. BMJ Open. 2019, 9, e023567.
[7]	Danjuma, M.I.; Sajid, J.; Fatima, H.; Elzouki, A.N. Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): a narrative perspective on current trends. Medicine(Baltimore). 2019, 98, e18322.
[8]	Bai, Z.F.; Wang, J.B.; Zhu, Y.; Xiao, X.H.; Song, H.B.; Li, C.Y. Integrated evidence chain-based identification of Chinese herbal medicine-induced hepatotoxicity and rational usage: Exemplification by Polygonum Multiflorum (He Shou wu). Chin. Sci. Bull. 2016, 61, 971–980.
[9]	Li, C.P.; Rao, T.; Chen, X.P.; Zou, Z.S.; Wei, A.W.; Tang, J.F.; Xiong, P.; Li, P.Y.; Jing, J.; He, T.T.; Bai, Z.F.; Yin, J.Y.; Tan, Z.R.; Yu, P.; Zhou, H.H.; Wang, J.B.; Xiao, X.H.; Ouyang, D.S. HLA-B35: 01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans. Hepatology.* 2019, 70, 346–357.
[10]	Meng, Y.K.; Li, C.Y.; Li, R.Y.; He, L.Z.; Cui, H.R.; Yin, P.; Zhang, C.E.; Li, P.Y.; Sang, X.X.; Wang, Y.; Niu, M.; Zhang, Y.M.; Guo, Y.M.; Sun, R.; Wang, J.B.; Bai, Z.F.; Xiao, X.H. Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-Γ. Acta Pharmacol. Sin. 2017, 38, 1340–1352.
[11]	He, L.Z.; Yin, P.; Meng, Y.K.; Tang, J.F.; He, T.T.; Niu, M.; Guo, Y.M.; Zhu, Y.; Jing, J.; Li, C.Y.; Ma, Z.J.; Wang, J.B.; Bai, Z.F.; Xiao, X.H. Immunological synergistic mechanisms of trans-/cis-stilbene glycosides in Heshouwu-related idiosyncratic liver injury. Sci. Bull. 2017, 62, 748–751.
[12]	Lin, L.F.; Lin, H.M.; Zhang, M.; Ni, B.R.; Yin, X.B.; Qu, C.H.; Ni, J. A novel method to analyze hepatotoxic components in Polygonum multiflorum using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J. Hazard. Mater. 2015, 299, 249–259.
[13]	Li, C.Y.; Niu, M.; Bai, Z.F.; Zhang, C.; Zhao, Y.L.; Li, R.Y.; Tu, C.; Li, H.F.; Jing, J.; Meng, Y.K.; Ma, Z.J.; Feng, W.W.; Tang, J.F.; Zhu, Y.; Li, J.J.; Shang, X.Y.; Zou, Z.S.; Xiao, X.H.; Wang, J.B. Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb, Polygonum multiflorum. Front. Med. 2017, 11, 253–265.
[14]	Bai, Z.; Gao, Y.; Zuo, X.; Wang, J.; Xiao, X. Progress in research on the pathogenesis of immune regulation and idiosyncratic drug-induced liver injury. Acta. Pharm. Sin. 2017, 52, 1019–1026.
[15]	Li, N.; Song, J.; Li, X.F.; Wang, Y.; Meng, Y.K.; Tu, C.; Li, C.Y.; Ma, Z.J.; Pang, J.Y.; Li, R.Y.; Xiao, X.H.; Kang, T.G.; Wang, J.B. Influence of drug metabolizing enzyme inhibitors on liver injury susceptibility to trans-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. Acta Pharm. Sin. 2017, 52, 1063–1068.
[16]	Wang, Y.; Wang, L.; Saxena, R.; Wee, A.; Yang, R.Y.; Tian, Q.J.; Zhang, J.P.; Zhao, X.Y.; Jia, J.D. Clinicopathological features of He Shou Wu-induced liver injury: This ancient anti-aging therapy is not liver-friendly. Liver Int. 2019, 39, 389–400.
[17]	Tu, C.; He, Q.; Li, C.Y.; Niu, M.; Han, Z.X.; Ge, F.L.; Zhou, Y.Y.; Zhang, L.; Wang, X.H.; Zhu, J.X.; Li, R.S.; Song, H.B.; Xiao, X.H.; Wang, J.B. Susceptibility-related factor and biomarkers of dietary supplement Polygonum multiflorum-induced liver injury in rats. Front. Pharmacol. 2019, 10, 335.
[18]	Zhang, C.E.; Niu, M.; Li, Q.; Zhao, Y.L.; Ma, Z.J.; Xiong, Y.; Dong, X.P.; Li, R.Y.; Feng, W.W.; Dong, Q.; Ma, X.; Zhu, Y.; Zou, Z.S.; Cao, J.L.; Wang, J.B.; Xiao, X.H. Urine metabolomics study on the liver injury in rats induced by raw and processed Polygonum multiflorum integrated with pattern recognition and pathways analysis. J. Ethnopharmacol. 2016, 194, 299–306.
[19]	Zhang, L.; Niu, M.; Wei, A.W.; Tang, J.F.; Tu, C.; Bai, Z.F.; Zou, Z.S.; Xiao, X.H.; Liu, Y.P.; Wang, J.B. Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Arch. Toxicol. 2020, 94, 245–256.
[20]	Gao, D.; Pang, J.Y.; Zhang, C.E.; Li, C.Y.; Tu, C.; Zhang, H.Z.; Niu, M.; Xiong, Y.; Xiao, X.H.; Zhao, K.J.; Gao, W.W.; Wang, J.B. Poria attenuates idiosyncratic liver injury induced by polygoni multiflori radix praeparata. Front. Pharmacol. 2016, 7, 386.